Is pancreatitis associated with meglumine antimoniate treatment for canine leishmaniosis? A multicentric prospective study
Abstract Background Meglumine antimoniate is used to treat canine leishmaniosis. In humans, it has been associated with pancreatitis. Although a few case reports have described acute pancreatitis secondary to antimonial treatment in dogs, some studies have concluded that pancreatitis is not an adver...
Saved in:
| Main Authors: | Clàudia Viñeta, Jorge Castro, María Cristina López, Maria Frau, Antón Costas, Carolina Arenas, Xavier Roura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Parasites & Vectors |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13071-024-06617-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High antimony resistance strain Enterobacter sp. Z1 mediates biomineralization of antimony trioxide
by: Zijie Zhou, et al.
Published: (2025-01-01) -
Identification of CβS and ODC antimony resistance markers in anthroponotic cutaneous leishmaniasis field isolates by gene expression profiling
by: Farzaneh Zarrinkar, et al.
Published: (2025-02-01) -
Study on antimony cake as a technogenic raw material for the production of antimony oxides
by: Kubat Kemelov, et al.
Published: (2021-12-01) -
Management of Canine Leishmaniasis and the Treatment Trends of Veterinarians in Aegean Region of Türkiye: A Questionnaire-based Survey
by: Metin Pekağırbaş, et al.
Published: (2024-12-01) -
Canine leishmaniasis caused by Leishmania tropica in southeastern Iran: a case series study
by: Baharak Akhtardanesh, et al.
Published: (2024-10-01)